Hillrom Improves Hypertension Detection With New Welch Allyn® Spot Vital Signs® 4400 Device

CHICAGO, Feb. 3, 2020 /PRNewswire/ -- Global medical technology leader Hillrom today announced the commercial launch of the new Welch Allyn® Spot Vital Signs® 4400, an easy-to-use next-generation vital signs device ideal for ambulatory and emergency department settings.

With its critical blood-pressure averaging feature, the new Spot Vital Signs 4400 device helps quickly and accurately detect hypertension(1) while digitally capturing other key vitals - temperature, pulse rate and pulse oximetry - in less than one minute.(2) Vitals information can easily be sent to the patient's electronic medical record.

"The Spot Vital Signs 4400 device offers a more efficient way to capture, access and document patient vitals than existing devices so clinicians can focus on what matters most--their patients," said Hillrom President and CEO John Groetelaars. "Integrating blood pressure averaging is a big advantage for caregivers, who will now have access to this key datapoint with the touch of a button, and can help diagnose hypertension more quickly and accurately."

The Welch Allyn Spot Vital Signs 4400 device is initially available in the United States and Canada, and will expand globally over the course of 2020.

About Hillrom
Hillrom is a global medical technology leader whose 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care(TM). Around the world, our innovations touch over 7 million patients each day. They help enable earlier diagnosis and treatment, optimize surgical efficiency and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. We make these outcomes possible through connected smart beds, patient lifts, patient assessment and monitoring technologies, caregiver collaboration tools, respiratory care devices, advanced operating room equipment and more, delivering actionable, real-time insights at the point of care. Learn more at Hillrom.com.

       
          CONTACT INFORMATION





       
          
                Investor Relations

    ---

               Contact:              
            Mary Kay Ladone, Senior Vice                                     Contact: 
     Lorna Williams, Executive


                                     
            President, Corporate                                                      
     Director, Investor Relations and


                                     
            Development, Strategy and                                                 
     Strategy


                                     
            Investor Relations                                      
     Phone:          
     312-233-7799


        Phone:                       
            312-819-9387                                            
     Email:          
     
              lorna.williams@hillrom.com


        Email:                       
            
              marykay.ladone@hillrom.com





       
          
                Media

    ---

               Contact:              
            Howard Karesh, Vice President, Corporate Communications


        Phone:                       
            312-819-7268


        Email:                       
            
              howard.karesh@hillrom.com

(1) Robert Smith, MD. Blood pressure averaging methodology: Decreasing the risk of misdiagnosing hypertension.
(2) Statistic based on clinical simulator.

View original content to download multimedia:http://www.prnewswire.com/news-releases/hillrom-improves-hypertension-detection-with-new-welch-allyn-spot-vital-signs-4400-device-300997382.html

SOURCE Hillrom